The 5 most recent market catalysts affecting $DH, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 2, 2026
Corporate Catalyst
Bullish
Impact 85
Definitive Healthcare shares are trading higher after the company confirmed the receipt of going-private proposal from Advent International. The company also announced the appointment of Clay Ritchey as its CEO.
This headline is a significant corporate catalyst for Definitive Healthcare (DH) as a going-private proposal typically involves a substantial premium over the current market price,…
Sep 2, 2026
Corporate Catalyst
Neutral
Impact 75
Definitive Healthcare Appoints Clay Ritchey CEO, Effective Sept. 8, Succeeding Kevin Coop
Definitive Healthcare announced a change in its top leadership, with Clay Ritchey replacing Kevin Coop as CEO and joining the Board of Directors, effective September 8, 2026. This …
Aug 10, 2026
Corporate Catalyst
Bullish
Impact 75
Definitive Healthcare shares are trading higher after the company reported better-than-expected Q2 adjusted EPS results and raised its FY26 adjusted EPS guidance.
This headline is a significant corporate catalyst for Definitive Healthcare (DH), as better-than-expected earnings and raised guidance directly impact investor confidence and valua…
Aug 10, 2026
Corporate Catalyst
Neutral
Impact 75
Definitive Healthcare Sees Q3 Adj EPS $0.04-$0.05 vs $0.04 Est; Sees Sales $54.000M-$55.000M vs $55.542M Est
Definitive Healthcare announced its Q3 2023 financial guidance, with adjusted EPS projected to be $0.04-$0.05, which is at or slightly above the analyst estimate of $0.04. However,…
Aug 10, 2026
Corporate Catalyst
Bearish
Impact 75
Definitive Healthcare Q2 Adj. EPS $0.05 Beats $0.04 Estimate, Sales $55.195M Miss $55.476M Estimate
Definitive Healthcare's Q2 earnings report shows a mixed performance. While adjusted EPS beat estimates, the sales miss and year-over-year declines in both EPS and sales are concer…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.